• Publications
  • Influence
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
TLDR
Recommendations for the core outcome domains that should be considered by investigators conducting clinical trials of the efficacy and effectiveness of treatments for chronic pain are provided. Expand
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
TLDR
Systematically collecting and reporting the recommended information needed to evaluate the clinical importance of treatment outcomes of Chronic pain clinical trials will allow additional validation of proposed benchmarks and provide more meaningful comparisons of chronic pain treatments. Expand
Pharmacologic management of neuropathic pain: Evidence-based recommendations
TLDR
Patients with neuropathic pain are challenging to manage and evidence‐based clinical recommendations for pharmacologic management are needed, and medications should be individualized, considering side effects, potential beneficial or deleterious effects on comorbidities, and whether prompt onset of pain relief is necessary. Expand
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
TLDR
The results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain and allow a strong recommendation for use and proposal as first-line treatment in neuropathicPain for tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin, and gabapentin. Expand
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.
TLDR
The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacological management of neuropathic pain and to provide a brief overview of several recent clinical trials. Expand
The prevalence of chronic pain in United States adults: results of an Internet-based survey.
TLDR
Chronic pain, experienced by about a third of the population, was correlated with indicators of poorer socioeconomic status and low household income and unemployment as significant socioeconomic correlates of chronic pain. Expand
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
TLDR
Randomized controlled clinical trials of gabapentin, the 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants provide an evidence-based approach to the treatment of neuropathic pain. Expand
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
TLDR
Although the CIPN trials are inconclusive regarding tricyclic antidepressants (such as nortriptyline), gabapentin, and a compounded topical gel containing baclofen, amitriptylines HCL, and ketamine, these agents may be offered on the basis of data supporting their utility in other neuropathic pain conditions given the limited other CIPn treatment options. Expand
Recommendations for the management of herpes zoster.
TLDR
The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacy Clovir as first-line antiviral therapy for the treatment of patients with HZ. Expand
An Interdisciplinary Expert Consensus Statement on Assessment of Pain in Older Persons
TLDR
Recommendations are provided regarding the physical examination and the assessment of pain using self-report and observational methods (suitable for seniors with dementia) and the physical and emotional functioning of older adults experiencing pain. Expand
...
1
2
3
4
5
...